chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Mycoplasma test negative, Pyrexia, Respiratory syncytial virus test negative, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Fever and chills  Myalgia  Viral syndrome  ED to Hosp-Admission Discharged  4/18/2021 - 4/22/2021 (4 days) Hospital  MD Last attending ? Treatment team Acute respiratory failure with hypoxia (CMS/HCC) Principal problem  Presenting Problem/History of Present Illness/Reason for Admission Acute respiratory failure with hypoxia (CMS/HCC) [J96.01] Pneumonia due to COVID-19 virus [U07.1, J12.82]   Hospital Course     This pleasant 54-year-old gentleman with history of hypertension came in with increasing shortness of breath and hypoxia secondary to Covid pneumonia resulting in hypoxic respiratory failure and diffuse pulmonary infiltrates.  Patient was hospitalized for management of severe sepsis secondary to Covid pneumonia resulting in acute hypoxic respiratory failure.  Patient was also treated for possible secondary bacterial pneumonia given duration of Covid symptoms prior to coming into hospital.  Patient made nice recovery and was able to wean off from high flow oxygen down to 2 L with exertion.  Patient overall made nice recovery hence he was discharged home.   Patient was noted to have rising D-dimers despite clinical improvement in Covid infection.  He is at high risk for developing DVTs hence he was recommended to use Xarelto 10 mg daily for 1 month to prevent any risk of DVTs.   Patient voiced understanding of this.  In he was discharged home with home health care.   His readmission potential is low to moderate.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Scan with contrast abnormal, Sepsis, Viral infection
Clinical narrative: Fever and chills  Myalgia  Viral syndrome  ED to Hosp-Admission Discharged  4/18/2021 - 4/22/2021 (4 days) Hospital  MD Last attending ? Treatment team Acute respiratory failure with hypoxia (CMS/HCC) Principal problem  Presenting Problem/History of Present Illness/Reason for Admission Acute respiratory failure with hypoxia (CMS/HCC) [J96.01] Pneumonia due to COVID-19 virus [U07.1, J12.82]   Hospital Course     This pleasant 54-year-old gentleman with history of hypertension came in with increasing shortness of breath and hypoxia secondary to Covid pneumonia resulting in hypoxic respiratory failure and diffuse pulmonary infiltrates.  Patient was hospitalized for management of severe sepsis secondary to Covid pneumonia resulting in acute hypoxic respiratory failure.  Patient was also treated for possible secondary bacterial pneumonia given duration of Covid symptoms prior to coming into hospital.  Patient made nice recovery and was able to wean off from high flow oxygen down to 2 L with exertion.  Patient overall made nice recovery hence he was discharged home.   Patient was noted to have rising D-dimers despite clinical improvement in Covid infection.  He is at high risk for developing DVTs hence he was recommended to use Xarelto 10 mg daily for 1 month to prevent any risk of DVTs.   Patient voiced understanding of this.  In he was discharged home with home health care.   His readmission potential is low to moderate.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Headache, Pain in extremity, Pruritus
Clinical narrative: ABDOMINAL PAIN; HOT FLASHES; DIARRHEA; ITCHY RASH  ALL OVER BODY; NO ENERGY; CHILLS; HEADACHE; TIREDNESS/ FATIGUE; CHEST TIGHTENING; GENERAL BLAH FEELING; ARM PAIN; MISSING WORK; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On MAY-2021, the subject experienced missing work. On 04-MAY-2021, the subject experienced chest tightening. On 04-MAY-2021, the subject experienced general blah feeling. On 04-MAY-2021, the subject experienced arm pain. On 04-MAY-2021, the subject experienced headache. On 04-MAY-2021, the subject experienced tiredness/ fatigue. On 12-MAY-2021, the subject experienced abdominal pain. On 12-MAY-2021, the subject experienced hot flashes. On 12-MAY-2021, the subject experienced diarrhea. On 12-MAY-2021, the subject experienced itchy rash all over body. On 12-MAY-2021, the subject experienced no energy. On 12-MAY-2021, the subject experienced chills. Treatment medications (dates unspecified) included: diphenhydramine hydrochloride, diphenhydramine hydrochloride/zinc oxide, and avena sativa. The action taken with covid-19 vaccine  was not applicable. The patient had not recovered from tiredness/ fatigue, headache, itchy rash all over body, no energy, abdominal pain, chills, and diarrhea, and the outcome of arm pain, chest tightening, general blah feeling, hot flashes and missing work was not reported. This report was non-serious.; Sender's Comments: v0-Medical Assessment Comment is not required as per standard procedures, as event was assessed as non-serious.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Asthenia, Chest discomfort, Chills, Diarrhoea
Clinical narrative: ABDOMINAL PAIN; HOT FLASHES; DIARRHEA; ITCHY RASH  ALL OVER BODY; NO ENERGY; CHILLS; HEADACHE; TIREDNESS/ FATIGUE; CHEST TIGHTENING; GENERAL BLAH FEELING; ARM PAIN; MISSING WORK; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On MAY-2021, the subject experienced missing work. On 04-MAY-2021, the subject experienced chest tightening. On 04-MAY-2021, the subject experienced general blah feeling. On 04-MAY-2021, the subject experienced arm pain. On 04-MAY-2021, the subject experienced headache. On 04-MAY-2021, the subject experienced tiredness/ fatigue. On 12-MAY-2021, the subject experienced abdominal pain. On 12-MAY-2021, the subject experienced hot flashes. On 12-MAY-2021, the subject experienced diarrhea. On 12-MAY-2021, the subject experienced itchy rash all over body. On 12-MAY-2021, the subject experienced no energy. On 12-MAY-2021, the subject experienced chills. Treatment medications (dates unspecified) included: diphenhydramine hydrochloride, diphenhydramine hydrochloride/zinc oxide, and avena sativa. The action taken with covid-19 vaccine  was not applicable. The patient had not recovered from tiredness/ fatigue, headache, itchy rash all over body, no energy, abdominal pain, chills, and diarrhea, and the outcome of arm pain, chest tightening, general blah feeling, hot flashes and missing work was not reported. This report was non-serious.; Sender's Comments: v0-Medical Assessment Comment is not required as per standard procedures, as event was assessed as non-serious.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Feeling abnormal, Headache, Hot flush, Impaired work ability
Clinical narrative: ABDOMINAL PAIN; HOT FLASHES; DIARRHEA; ITCHY RASH  ALL OVER BODY; NO ENERGY; CHILLS; HEADACHE; TIREDNESS/ FATIGUE; CHEST TIGHTENING; GENERAL BLAH FEELING; ARM PAIN; MISSING WORK; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On MAY-2021, the subject experienced missing work. On 04-MAY-2021, the subject experienced chest tightening. On 04-MAY-2021, the subject experienced general blah feeling. On 04-MAY-2021, the subject experienced arm pain. On 04-MAY-2021, the subject experienced headache. On 04-MAY-2021, the subject experienced tiredness/ fatigue. On 12-MAY-2021, the subject experienced abdominal pain. On 12-MAY-2021, the subject experienced hot flashes. On 12-MAY-2021, the subject experienced diarrhea. On 12-MAY-2021, the subject experienced itchy rash all over body. On 12-MAY-2021, the subject experienced no energy. On 12-MAY-2021, the subject experienced chills. Treatment medications (dates unspecified) included: diphenhydramine hydrochloride, diphenhydramine hydrochloride/zinc oxide, and avena sativa. The action taken with covid-19 vaccine  was not applicable. The patient had not recovered from tiredness/ fatigue, headache, itchy rash all over body, no energy, abdominal pain, chills, and diarrhea, and the outcome of arm pain, chest tightening, general blah feeling, hot flashes and missing work was not reported. This report was non-serious.; Sender's Comments: v0-Medical Assessment Comment is not required as per standard procedures, as event was assessed as non-serious.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Rash pruritic
Clinical narrative: ABDOMINAL PAIN; HOT FLASHES; DIARRHEA; ITCHY RASH  ALL OVER BODY; NO ENERGY; CHILLS; HEADACHE; TIREDNESS/ FATIGUE; CHEST TIGHTENING; GENERAL BLAH FEELING; ARM PAIN; MISSING WORK; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On MAY-2021, the subject experienced missing work. On 04-MAY-2021, the subject experienced chest tightening. On 04-MAY-2021, the subject experienced general blah feeling. On 04-MAY-2021, the subject experienced arm pain. On 04-MAY-2021, the subject experienced headache. On 04-MAY-2021, the subject experienced tiredness/ fatigue. On 12-MAY-2021, the subject experienced abdominal pain. On 12-MAY-2021, the subject experienced hot flashes. On 12-MAY-2021, the subject experienced diarrhea. On 12-MAY-2021, the subject experienced itchy rash all over body. On 12-MAY-2021, the subject experienced no energy. On 12-MAY-2021, the subject experienced chills. Treatment medications (dates unspecified) included: diphenhydramine hydrochloride, diphenhydramine hydrochloride/zinc oxide, and avena sativa. The action taken with covid-19 vaccine  was not applicable. The patient had not recovered from tiredness/ fatigue, headache, itchy rash all over body, no energy, abdominal pain, chills, and diarrhea, and the outcome of arm pain, chest tightening, general blah feeling, hot flashes and missing work was not reported. This report was non-serious.; Sender's Comments: v0-Medical Assessment Comment is not required as per standard procedures, as event was assessed as non-serious.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Headache, Injection site pain, Nystagmus, Photophobia
Clinical narrative: suddenly developed nystagmus; arm was sore for 2 days; This is a spontaneous report received from a contactable consumer (patient).   A 44-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration (at the age of 44-years-old), administered in Arm Left on 17Apr2021 12:15 (Lot Number: ER8731) as 1st dose, single for COVID-19 immunization. Medical history included Penicillin allergy, Mango skin allergies, poison ivy allergies, and very spotty history of migraine with visual phenomena fewer than 10 episodes my whole life. The patient was not pregnant. Concomitant medication included ethinylestradiol, norgestimate (ORTHO TRI-CYCLEN) taken for an unspecified indication, start and stop date were not reported. The patient stated, "After the vaccine (17Apr2021), my arm was sore for 2 days, no other effects. A week later, I was lying on my right side and suddenly developed nystagmus on 24Apr2021 11:00 AM. It subsided in a few minutes but has continued every morning after I wake up, clearly a result of lying on my right side. No other triggers: I am able to function normally (driving, biking, reading, computer use), but it has not subsided. I have a doctor's appointment scheduled next week." No treatment received for events. The events resulted in Doctor or other healthcare professional office/clinic visit. The outcome of arm was sore for 2 days was recovered on 19Apr2021 while for nystagmus was not recovered. The events were reported as non-serious.  The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Visual impairment, Vitreous floaters
Clinical narrative: suddenly developed nystagmus; arm was sore for 2 days; This is a spontaneous report received from a contactable consumer (patient).   A 44-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration (at the age of 44-years-old), administered in Arm Left on 17Apr2021 12:15 (Lot Number: ER8731) as 1st dose, single for COVID-19 immunization. Medical history included Penicillin allergy, Mango skin allergies, poison ivy allergies, and very spotty history of migraine with visual phenomena fewer than 10 episodes my whole life. The patient was not pregnant. Concomitant medication included ethinylestradiol, norgestimate (ORTHO TRI-CYCLEN) taken for an unspecified indication, start and stop date were not reported. The patient stated, "After the vaccine (17Apr2021), my arm was sore for 2 days, no other effects. A week later, I was lying on my right side and suddenly developed nystagmus on 24Apr2021 11:00 AM. It subsided in a few minutes but has continued every morning after I wake up, clearly a result of lying on my right side. No other triggers: I am able to function normally (driving, biking, reading, computer use), but it has not subsided. I have a doctor's appointment scheduled next week." No treatment received for events. The events resulted in Doctor or other healthcare professional office/clinic visit. The outcome of arm was sore for 2 days was recovered on 19Apr2021 while for nystagmus was not recovered. The events were reported as non-serious.  The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nystagmus, Pain in extremity
Clinical narrative: suddenly developed nystagmus; arm was sore for 2 days; This is a spontaneous report received from a contactable consumer (patient).   A 44-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration (at the age of 44-years-old), administered in Arm Left on 17Apr2021 12:15 (Lot Number: ER8731) as 1st dose, single for COVID-19 immunization. Medical history included Penicillin allergy, Mango skin allergies, poison ivy allergies, and very spotty history of migraine with visual phenomena fewer than 10 episodes my whole life. The patient was not pregnant. Concomitant medication included ethinylestradiol, norgestimate (ORTHO TRI-CYCLEN) taken for an unspecified indication, start and stop date were not reported. The patient stated, "After the vaccine (17Apr2021), my arm was sore for 2 days, no other effects. A week later, I was lying on my right side and suddenly developed nystagmus on 24Apr2021 11:00 AM. It subsided in a few minutes but has continued every morning after I wake up, clearly a result of lying on my right side. No other triggers: I am able to function normally (driving, biking, reading, computer use), but it has not subsided. I have a doctor's appointment scheduled next week." No treatment received for events. The events resulted in Doctor or other healthcare professional office/clinic visit. The outcome of arm was sore for 2 days was recovered on 19Apr2021 while for nystagmus was not recovered. The events were reported as non-serious.  The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Injection site pain, Loss of personal independence in daily activities, Paraesthesia
Clinical narrative: Administered incorrectly  Impaired mobility  Weakness  Tingling  Painful
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Nasopharyngitis, Pain in extremity, Paraesthesia, Sensory loss, Tenderness
Clinical narrative: Administered incorrectly  Impaired mobility  Weakness  Tingling  Painful
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, Pain in extremity, Paraesthesia, Product administered at inappropriate site
Clinical narrative: Administered incorrectly  Impaired mobility  Weakness  Tingling  Painful
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myocardial infarction
Clinical narrative: Mild heart attack,Raised triponin levels; Mild heart attack,Raised triponin levels; This is a spontaneous report from a contactable consumer (patient). A 36-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot Number: Er8729), via an unspecified route of administration, administered in Arm Left on 10Apr2021 (36-years-old) as 1st dose, single for COVID-19 immunization. The patient medical history included that prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. Facility where the most recent COVID-19 vaccine was administered was Pharmacy or Drug Store. Patient was not pregnant at time of vaccination. Concomitant medications were not reported. The patient experienced mild heart attack, raised triponin levels on 12Apr2021 with outcome of recovering.  The patient underwent lab tests and procedures which included Nasal Swab: negative on 12Apr2021. The adverse events resulted in Emergency room/department or urgent care. Treatment received for the adverse event was Medication, Angiogram, ultrasound, bloodwork, cats. Therapeutic measures were taken as a result of events.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiogram, Blood test, Myocardial infarction, SARS-CoV-2 test, Troponin increased
Clinical narrative: Mild heart attack,Raised triponin levels; Mild heart attack,Raised triponin levels; This is a spontaneous report from a contactable consumer (patient). A 36-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot Number: Er8729), via an unspecified route of administration, administered in Arm Left on 10Apr2021 (36-years-old) as 1st dose, single for COVID-19 immunization. The patient medical history included that prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. Facility where the most recent COVID-19 vaccine was administered was Pharmacy or Drug Store. Patient was not pregnant at time of vaccination. Concomitant medications were not reported. The patient experienced mild heart attack, raised triponin levels on 12Apr2021 with outcome of recovering.  The patient underwent lab tests and procedures which included Nasal Swab: negative on 12Apr2021. The adverse events resulted in Emergency room/department or urgent care. Treatment received for the adverse event was Medication, Angiogram, ultrasound, bloodwork, cats. Therapeutic measures were taken as a result of events.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ultrasound scan
Clinical narrative: Mild heart attack,Raised triponin levels; Mild heart attack,Raised triponin levels; This is a spontaneous report from a contactable consumer (patient). A 36-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot Number: Er8729), via an unspecified route of administration, administered in Arm Left on 10Apr2021 (36-years-old) as 1st dose, single for COVID-19 immunization. The patient medical history included that prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. Facility where the most recent COVID-19 vaccine was administered was Pharmacy or Drug Store. Patient was not pregnant at time of vaccination. Concomitant medications were not reported. The patient experienced mild heart attack, raised triponin levels on 12Apr2021 with outcome of recovering.  The patient underwent lab tests and procedures which included Nasal Swab: negative on 12Apr2021. The adverse events resulted in Emergency room/department or urgent care. Treatment received for the adverse event was Medication, Angiogram, ultrasound, bloodwork, cats. Therapeutic measures were taken as a result of events.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test normal, Fatigue, Impaired driving ability, Impaired work ability, Loss of personal independence in daily activities
Clinical narrative: debilitating vertigo; fatigue; headaches; migraine; been laid out flat; This is a spontaneous report from a contactable consumer (patient). A 39-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration, administered in the left arm, on 02Apr2021 16:00, as 1st dose, single, for COVID-19 immunisation, at an urgent care center. Medical history included hypothyroidism and known allergies to penicillin, sulfa and avocado. The patient did not have COVID-19 prior to vaccination and was not tested for COVID-19 post vaccination. The patient was not pregnant at the time of vaccination. Concomitant medications included levothyroxine, cyclobenzaprine and multivitamins, all taken for unspecified indications, start and stop dates were not reported. The patient previously took cefaclor (CELCOR) and experienced allergy. The patient did not receive other vaccines in four weeks. The patient reported that she was in great health and had blood drawn out in Apr2021 which was great. On 02Apr2021, the patient received the first dose of COVID-19 vaccine. On the same day, 02Apr2021, at 18:00, the patient experienced debilitating vertigo, fatigue, headaches and migraine. The patient reported he has been laid out flat for almost 5 weeks since getting the first dose. The patient stated that this was a disability as he was very well before. The events resulted to physician's office visit. The patient assessed the events as serious (disability or permanent damage). Treatment for the events included unspecified vertigo and migraine medicine and immune boost IV. The outcome of the events was not resolved.  Information about lot and batch number was requested.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Migraine, Vertigo
Clinical narrative: debilitating vertigo; fatigue; headaches; migraine; been laid out flat; This is a spontaneous report from a contactable consumer (patient). A 39-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration, administered in the left arm, on 02Apr2021 16:00, as 1st dose, single, for COVID-19 immunisation, at an urgent care center. Medical history included hypothyroidism and known allergies to penicillin, sulfa and avocado. The patient did not have COVID-19 prior to vaccination and was not tested for COVID-19 post vaccination. The patient was not pregnant at the time of vaccination. Concomitant medications included levothyroxine, cyclobenzaprine and multivitamins, all taken for unspecified indications, start and stop dates were not reported. The patient previously took cefaclor (CELCOR) and experienced allergy. The patient did not receive other vaccines in four weeks. The patient reported that she was in great health and had blood drawn out in Apr2021 which was great. On 02Apr2021, the patient received the first dose of COVID-19 vaccine. On the same day, 02Apr2021, at 18:00, the patient experienced debilitating vertigo, fatigue, headaches and migraine. The patient reported he has been laid out flat for almost 5 weeks since getting the first dose. The patient stated that this was a disability as he was very well before. The events resulted to physician's office visit. The patient assessed the events as serious (disability or permanent damage). Treatment for the events included unspecified vertigo and migraine medicine and immune boost IV. The outcome of the events was not resolved.  Information about lot and batch number was requested.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Fatigue, Headache, Migraine, Mobility decreased
Clinical narrative: debilitating vertigo; fatigue; headaches; migraine; been laid out flat; This is a spontaneous report from a contactable consumer (patient). A 39-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration, administered in the left arm, on 02Apr2021 16:00, as 1st dose, single, for COVID-19 immunisation, at an urgent care center. Medical history included hypothyroidism and known allergies to penicillin, sulfa and avocado. The patient did not have COVID-19 prior to vaccination and was not tested for COVID-19 post vaccination. The patient was not pregnant at the time of vaccination. Concomitant medications included levothyroxine, cyclobenzaprine and multivitamins, all taken for unspecified indications, start and stop dates were not reported. The patient previously took cefaclor (CELCOR) and experienced allergy. The patient did not receive other vaccines in four weeks. The patient reported that she was in great health and had blood drawn out in Apr2021 which was great. On 02Apr2021, the patient received the first dose of COVID-19 vaccine. On the same day, 02Apr2021, at 18:00, the patient experienced debilitating vertigo, fatigue, headaches and migraine. The patient reported he has been laid out flat for almost 5 weeks since getting the first dose. The patient stated that this was a disability as he was very well before. The events resulted to physician's office visit. The patient assessed the events as serious (disability or permanent damage). Treatment for the events included unspecified vertigo and migraine medicine and immune boost IV. The outcome of the events was not resolved.  Information about lot and batch number was requested.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vertigo
Clinical narrative: debilitating vertigo; fatigue; headaches; migraine; been laid out flat; This is a spontaneous report from a contactable consumer (patient). A 39-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration, administered in the left arm, on 02Apr2021 16:00, as 1st dose, single, for COVID-19 immunisation, at an urgent care center. Medical history included hypothyroidism and known allergies to penicillin, sulfa and avocado. The patient did not have COVID-19 prior to vaccination and was not tested for COVID-19 post vaccination. The patient was not pregnant at the time of vaccination. Concomitant medications included levothyroxine, cyclobenzaprine and multivitamins, all taken for unspecified indications, start and stop dates were not reported. The patient previously took cefaclor (CELCOR) and experienced allergy. The patient did not receive other vaccines in four weeks. The patient reported that she was in great health and had blood drawn out in Apr2021 which was great. On 02Apr2021, the patient received the first dose of COVID-19 vaccine. On the same day, 02Apr2021, at 18:00, the patient experienced debilitating vertigo, fatigue, headaches and migraine. The patient reported he has been laid out flat for almost 5 weeks since getting the first dose. The patient stated that this was a disability as he was very well before. The events resulted to physician's office visit. The patient assessed the events as serious (disability or permanent damage). Treatment for the events included unspecified vertigo and migraine medicine and immune boost IV. The outcome of the events was not resolved.  Information about lot and batch number was requested.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Chills, Migraine, Nausea, Pyrexia
Clinical narrative: kidney inflammation; Fever up to 104.7 degrees; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EW0162), via an unspecified route of administration, administered in the left arm, on 18Apr2021, as 2nd dose, single, for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination. Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ER8732), on an unspecified date, for COVID-19 immunisation. It was reported that the patient had fever up to 104.7 degrees and kidney inflammation when she went to the hospital (pending clarification) in the morning of 05May2021. The events resulted to physician's office visit. The patient was prescribed with unspecified treatment for the events. The outcome of the events was unknown.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Nephritis, Pyrexia
Clinical narrative: kidney inflammation; Fever up to 104.7 degrees; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EW0162), via an unspecified route of administration, administered in the left arm, on 18Apr2021, as 2nd dose, single, for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination. Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ER8732), on an unspecified date, for COVID-19 immunisation. It was reported that the patient had fever up to 104.7 degrees and kidney inflammation when she went to the hospital (pending clarification) in the morning of 05May2021. The events resulted to physician's office visit. The patient was prescribed with unspecified treatment for the events. The outcome of the events was unknown.
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Aspiration, Cough, Dyspnoea, Loss of consciousness, Vomiting
Clinical narrative: First COVID vaccine 5/4/21, moderna. Had SE and pharmacist recommend doc recommendation for 2nd vaccine.    Day of vaccine felt fine.  Next morning 5/5/21 had headache.  At 11am took nap and was having an episode almost like "sleep paralysis" where he would wake up feeling like he couldn't move and gasping for air.  He reports he did this sleeping and waking for about 1 hour (he had no problems sleeping the night before.)  He woke up after an hour and had vomited in his sleep - he thinks he choked a bit on it.  But when he woke up his breathing was normal, movement normal.   He then only experienced fatigue and headache for the rest of the day.  Then by next day felt totally normal.
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Fatigue, Headache, Mobility decreased, Sleep paralysis
Clinical narrative: First COVID vaccine 5/4/21, moderna. Had SE and pharmacist recommend doc recommendation for 2nd vaccine.    Day of vaccine felt fine.  Next morning 5/5/21 had headache.  At 11am took nap and was having an episode almost like "sleep paralysis" where he would wake up feeling like he couldn't move and gasping for air.  He reports he did this sleeping and waking for about 1 hour (he had no problems sleeping the night before.)  He woke up after an hour and had vomited in his sleep - he thinks he choked a bit on it.  But when he woke up his breathing was normal, movement normal.   He then only experienced fatigue and headache for the rest of the day.  Then by next day felt totally normal.
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: First COVID vaccine 5/4/21, moderna. Had SE and pharmacist recommend doc recommendation for 2nd vaccine.    Day of vaccine felt fine.  Next morning 5/5/21 had headache.  At 11am took nap and was having an episode almost like "sleep paralysis" where he would wake up feeling like he couldn't move and gasping for air.  He reports he did this sleeping and waking for about 1 hour (he had no problems sleeping the night before.)  He woke up after an hour and had vomited in his sleep - he thinks he choked a bit on it.  But when he woke up his breathing was normal, movement normal.   He then only experienced fatigue and headache for the rest of the day.  Then by next day felt totally normal.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Computerised tomogram, Fatigue, Gait inability, Muscular weakness
Clinical narrative: Tired; Could not walk; This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) 1st dose (lot number EWD162 ) on 13Apr2021 13:00, 2nd dose (lot number EWD150) on 04May2021 12:15, both via an unknown route in left arm for Covid-19 immunization. Medical history included liver transplant recipient, and knee replacement, allergies with torvastatin (LIPITOR) and simvastatin. Concomitant drug was not provided. Patient received other medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Serious adverse event was reported as tired and could not walk with onset date of 04May2021 21:00 and seriousness criterion of hospitalizing of 5 days. The clinical course was reported as follows: In the evening of the same date as vaccinated, the patient became tired and could not walk. She was transported to the Emergency Room of Hospital for treatment and was admitted for further testing, observation and treatment; she remained in that hospital. Prior to vaccination, the patient was not diagnosed with COVID-19. Nasal Swab on 5May2021 result was unknown.  Outcome of the events was resolving.    Information on lot/batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urine analysis, X-ray
Clinical narrative: Tired; Could not walk; This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) 1st dose (lot number EWD162 ) on 13Apr2021 13:00, 2nd dose (lot number EWD150) on 04May2021 12:15, both via an unknown route in left arm for Covid-19 immunization. Medical history included liver transplant recipient, and knee replacement, allergies with torvastatin (LIPITOR) and simvastatin. Concomitant drug was not provided. Patient received other medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Serious adverse event was reported as tired and could not walk with onset date of 04May2021 21:00 and seriousness criterion of hospitalizing of 5 days. The clinical course was reported as follows: In the evening of the same date as vaccinated, the patient became tired and could not walk. She was transported to the Emergency Room of Hospital for treatment and was admitted for further testing, observation and treatment; she remained in that hospital. Prior to vaccination, the patient was not diagnosed with COVID-19. Nasal Swab on 5May2021 result was unknown.  Outcome of the events was resolving.    Information on lot/batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Gait inability, SARS-CoV-2 test
Clinical narrative: Tired; Could not walk; This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) 1st dose (lot number EWD162 ) on 13Apr2021 13:00, 2nd dose (lot number EWD150) on 04May2021 12:15, both via an unknown route in left arm for Covid-19 immunization. Medical history included liver transplant recipient, and knee replacement, allergies with torvastatin (LIPITOR) and simvastatin. Concomitant drug was not provided. Patient received other medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Serious adverse event was reported as tired and could not walk with onset date of 04May2021 21:00 and seriousness criterion of hospitalizing of 5 days. The clinical course was reported as follows: In the evening of the same date as vaccinated, the patient became tired and could not walk. She was transported to the Emergency Room of Hospital for treatment and was admitted for further testing, observation and treatment; she remained in that hospital. Prior to vaccination, the patient was not diagnosed with COVID-19. Nasal Swab on 5May2021 result was unknown.  Outcome of the events was resolving.    Information on lot/batch number has been requested.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram thorax abnormal, Condition aggravated, Deep vein thrombosis, Echocardiogram, Loss of consciousness
Clinical narrative: large saddle blood clot in the patient's lungs; putting a strain on the patient's heart; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number and expiry date unknown), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunization.  Medical history included blood clot from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported.  It was reported that on an unspecified date, 20 days after receiving the first dose of the COVID vaccine, the patient admitted in the hospital with a large saddle blood clot in the patient's lungs putting a strain on the patient's heart. The patient stated that there should be more warnings for people that have had devious blood clots. The patient stated that he/she could have died. The outcome of the events was unknown.   Information about lot/batch number has been requested.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Pulmonary embolism, Ultrasound Doppler abnormal
Clinical narrative: large saddle blood clot in the patient's lungs; putting a strain on the patient's heart; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number and expiry date unknown), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunization.  Medical history included blood clot from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported.  It was reported that on an unspecified date, 20 days after receiving the first dose of the COVID vaccine, the patient admitted in the hospital with a large saddle blood clot in the patient's lungs putting a strain on the patient's heart. The patient stated that there should be more warnings for people that have had devious blood clots. The patient stated that he/she could have died. The outcome of the events was unknown.   Information about lot/batch number has been requested.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Cardiac disorder, Pulmonary thrombosis
Clinical narrative: large saddle blood clot in the patient's lungs; putting a strain on the patient's heart; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number and expiry date unknown), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunization.  Medical history included blood clot from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported.  It was reported that on an unspecified date, 20 days after receiving the first dose of the COVID vaccine, the patient admitted in the hospital with a large saddle blood clot in the patient's lungs putting a strain on the patient's heart. The patient stated that there should be more warnings for people that have had devious blood clots. The patient stated that he/she could have died. The outcome of the events was unknown.   Information about lot/batch number has been requested.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal pain upper, Dyspnoea, Fatigue, Haemoptysis, Rash
Clinical narrative: Death on 5/7/2021
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Death
Clinical narrative: Death on 5/7/2021
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: first covid vaccination on January 25th. 3 days later /"covid symptoms/experience as severe flu symptoms/ test confirmed covid; This is spontaneous report received from a contactable consumer (patient). A 66-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration on 25Jan2021 as 1st dose, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient received his first covid vaccination on January 25th. 3 days later he began to experience "covid symptoms" further explaining his experience as severe flu symptoms. A couple of days later a test confirmed covid. He did not take the second vaccine dose reporting, he knew you would be good for 3 months and he wanted to wait for any new information that would come out about the vaccine. He still hasn't gotten his second dose. The outcome of the event was unknown.   Information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Influenza, Malaise, SARS-CoV-2 test positive
Clinical narrative: first covid vaccination on January 25th. 3 days later /"covid symptoms/experience as severe flu symptoms/ test confirmed covid; This is spontaneous report received from a contactable consumer (patient). A 66-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration on 25Jan2021 as 1st dose, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient received his first covid vaccination on January 25th. 3 days later he began to experience "covid symptoms" further explaining his experience as severe flu symptoms. A couple of days later a test confirmed covid. He did not take the second vaccine dose reporting, he knew you would be good for 3 months and he wanted to wait for any new information that would come out about the vaccine. He still hasn't gotten his second dose. The outcome of the event was unknown.   Information about lot/batch number cannot be obtained.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abscess drainage, Aphasia, Blood test, Chest X-ray, Computerised tomogram
Clinical narrative: I was hospitalized with high fever; swollen salivary glands with no drainage; This is a spontaneous report from COVAES from a contactable consumer (patient).   A 64-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Left Arm on 20Apr2021 14:00 (Batch/Lot Number: Unknown) as 2ND DOSE, SINGLE (at the age of 64 years) for covid-19 immunisation.  The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number unknown) 29Mar2021 at 12:30 PM, in Left arm.  Medical history included asthma from an unknown date and unknown if ongoing and drug hypersensitivity to penicillin.  The patient's concomitant medications were not reported.  The patient did not receive any other medication within 2 weeks of vaccination.  Prior to vaccination the patient was not diagnosed with COVID-19.  The patient experienced hospitalization for high fever on 21Apr2021 with outcome of recovered and swollen salivary glands with no drainage (hospitalization) on 21Apr2021 with outcome of recovered.  The patient's hospitalization was prolonged as a result of these events.  The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 21Apr2021.  Therapeutic measures were taken as a result of high fever and swollen salivary glands with no drainage. The patient was not pregnant at time of Vaccination. The patient did not receive "any other" vaccines within 4 weeks prior to the COVID vaccine.    Information on the lot/batch number has been requested.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeding disorder, Lymphadenopathy, Pain, Pustule, Pyrexia
Clinical narrative: I was hospitalized with high fever; swollen salivary glands with no drainage; This is a spontaneous report from COVAES from a contactable consumer (patient).   A 64-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Left Arm on 20Apr2021 14:00 (Batch/Lot Number: Unknown) as 2ND DOSE, SINGLE (at the age of 64 years) for covid-19 immunisation.  The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number unknown) 29Mar2021 at 12:30 PM, in Left arm.  Medical history included asthma from an unknown date and unknown if ongoing and drug hypersensitivity to penicillin.  The patient's concomitant medications were not reported.  The patient did not receive any other medication within 2 weeks of vaccination.  Prior to vaccination the patient was not diagnosed with COVID-19.  The patient experienced hospitalization for high fever on 21Apr2021 with outcome of recovered and swollen salivary glands with no drainage (hospitalization) on 21Apr2021 with outcome of recovered.  The patient's hospitalization was prolonged as a result of these events.  The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 21Apr2021.  Therapeutic measures were taken as a result of high fever and swollen salivary glands with no drainage. The patient was not pregnant at time of Vaccination. The patient did not receive "any other" vaccines within 4 weeks prior to the COVID vaccine.    Information on the lot/batch number has been requested.